Trial Profile
Phase I/II Multisite, Randomized, Controlled Study of Monoclonal Antibody VRC01 With Combination Antiretroviral Therapy to Promote Clearance of HIV-1-Infected Cells in Infants
Status:
Completed
Phase of Trial:
Phase I/II
Latest Information Update: 26 May 2023
Price :
$35
*
At a glance
- Drugs VRC 01LS (Primary)
- Indications HIV-1 infections
- Focus Adverse reactions; Therapeutic Use
- Acronyms IMPAACT 2008
- 02 Aug 2022 Results presented at the 24th International AIDS Conference
- 18 Jun 2021 Status changed from active, no longer recruiting to completed.
- 11 May 2020 Planned End Date changed from 1 Jul 2021 to 10 Feb 2021.